Purdy et al v. Wyeth Inc et al
| Joann Purdy and Alan Purdy |
| Wyeth Inc, Wyeth Pharmaceuticals Inc, ESI Lederle, Wyeth Ayerst International Inc, Pharmacia Corporation, Pfizer Inc, Greenstone Ltd, Barr Pharmaceuticals Inc, Barr Laboratories Inc, Duramed Pharmaceuticals Inc, Bristol Myers Squibb Company, Solvay Pharmaceuticals Inc, Novo Nordisk Inc, Novartis Pharmaceuticals Corporation, Mead Johnson & Company, Warner Chilcott Inc, Watson Pharmaceuticals Inc and Pharmacia & Upjohn Company |
| 4:2008cv02700 |
| September 17, 2008 |
| US District Court for the Eastern District of Arkansas |
| Personal Inj. Prod. Liability Office |
| Out of State |
| Billy Roy Wilson |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 20, 2014. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 37
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #36 Plaintiff's Motion to Dismiss With Prejudice. Accordingly, this CASE is DISMISSED with prejudice. Signed by Judge Billy Roy Wilson on 05/20/14. (dmm)
|
| Filing 36 MOTION to Dismiss by All Plaintiffs (Morrison, Matthew) |
|
Filing 35
ORDER designating cases to proceed with case-specific discovery under Practice and Procedure Order 9. Plaintiff(s) are directed to provide Defendant(s) with updated medical authorization within 3 weeks of the date of this Order. Signed by Judge Billy Roy Wilson on 1/29/2013. (jak)
|
| Filing 34 NOTICE of Appearance by Edward F. Fox on behalf of Wyeth Ayerst International Inc, Wyeth Inc, Wyeth Pharmaceuticals Inc (Fox, Edward) |
| Filing 33 NOTICE of Appearance by Carrie L Hund on behalf of Wyeth Ayerst International Inc, Wyeth Inc, Wyeth Pharmaceuticals Inc (Hund, Carrie) |
| Filing 32 NOTICE of Appearance by Matthew J. Morrison on behalf of Joann Purdy, Alan Purdy (Morrison, Matthew) |
| Filing 31 NOTICE of Appearance by Carrie L Hund on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc (Hund, Carrie) |
| Filing 30 NOTICE of Appearance by Edward F. Fox on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc (Fox, Edward) |
|
Filing 29
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #28 Defendant's PPO8 Motion to Dismiss. Accordingly, Novo Nordisk, Inc. is DISMISSED based on the terms and conditions in PPO8. Signed by Judge William R. Wilson, Jr on 10/29/08. (dmm)
|
| Filing 28 MOTION to Dismiss PURSUANT TO PRACTICE AND PROCEDURE ORDER NO. 8 by Novo Nordisk Inc (Sterchi, Thomas) |
|
Filing 27
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #26 Defendants' PPO 8 Motion to Dismiss. Accordingly, Defendants Barr Laboratories, Inc., Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Mead-Johnson & Company, Solvay Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Watson Pharmaceuticals, Inc., and Warner-Chilcott, Inc. are DISMISSED based on the terms and conditions in PPO 8. Signed by Judge William R. Wilson, Jr on 10/15/08. (dmm)
|
| Filing 26 MOTION to Dismiss Defendants Barr Laboratories, Inc., Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Mead-Johnson & Company, Solvay Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Watson Pharmaceuticals, Inc., and Warner-Chilcott, Inc. Pursuant to Practice and Procedure Order No. 8 by Barr Pharmaceuticals Inc, Barr Laboratories Inc, Duramed Pharmaceuticals Inc (Saelinger, Gina) |
| Filing 25 Corporate Disclosure Statement (Rule 7.1) by Novo Nordisk Inc (Lysaught, Patrick) |
| Filing 24 ANSWER to Complaint with Jury Demand and Affirmative Defenses by Novo Nordisk Inc.(Lysaught, Patrick) |
| Filing 23 NOTICE of Appearance by Paul S. Penticuff on behalf of Novo Nordisk Inc (Penticuff, Paul) |
| Filing 22 NOTICE of Appearance by Patrick Lysaught on behalf of Novo Nordisk Inc (Lysaught, Patrick) |
| Filing 21 NOTICE of Appearance by Thomas N. Sterchi on behalf of Novo Nordisk Inc (Sterchi, Thomas) |
| Filing 20 NOTICE of Appearance by Kerry Carson Green on behalf of Watson Pharmaceuticals Inc (Green, Kerry) |
| Filing 18 MEMORANDUM to counsel from the Clerk of Court re: receipt of case from transferor court with a copy of Standing Order dated 8/11/2005 filed in 4:03-cv-1507 attached. (rhm) |
| Filing 17 NOTICE of Appearance by Brian A. Troyer on behalf of Solvay Pharmaceuticals Inc (Troyer, Brian) |
| Filing 16 Case electronically transferred in from District of Minnesota; Case Number 0:08-cv-04426. Electronic file with documents numbered 1 - 15, copy of transfer order and docket sheet received. |
| Filing 15 Certified Copy of Transfer Order (CTO-145) from the Judicial Panel on Multi-District Litigation; transferring case to the Eastern District of Arkansas for coordinated or consolidated pretrial proceedings. Case assigned to Judge William R Wilson, Jr. (kt) [Transferred from mnd on 9/17/2008.] |
|
Filing 14
ORDER OF RECUSAL. Judge Ann D. Montgomery recused. Case reassigned to Senior Judge Paul A. Magnuson for all further proceedings. NOTE: the new case number is 08cv4426 PAM/JJG. Please use this case number for all subsequent pleadings. Signed by Judge Ann D. Montgomery on 8/8/08. (JME) [Transferred from mnd on 9/17/2008.]
|
|
Filing 13
ADMINISTRATIVE ORDER NO. 1 - Establishing Administrative Case 0:08-ad-0001 for management of Hormone Replacement Therapy Litigation cases in the District of Minnesota. IT IS ORDERED that: Defendants in any HRT action filed in this Court after June 1, 2008 need not answer, or otherwise respond to Plaintiffs' HRT complaints until twenty (20) days after notice of formal transfer or further Order of this Court. It is further Ordered that Defendants who have previously filed a Rule 7.1 Disclosure Statement need not file any further such disclosures unless there is a material change in corporate information. Signed by Chief Judge Michael J. Davis on 7/30/08. (Attachments: #1 Case List) Associated Cases: 0:08-ad-00001 et al. This Order will be entered multiple times for groups of HRT cases filed in the District of Minnesota. (LJG) [Transferred from mnd on 9/17/2008.]
|
| Filing 12 CERTIFICATE OF SERVICE by Novartis Pharmaceuticals Corporation re #10 Notice of Appearance, #11 Rule 7.1 - Disclosure Statement (Freestone, Amy) [Transferred from mnd on 9/17/2008.] |
| Filing 11 RULE 7.1 DISCLOSURE STATEMENT by Novartis Pharmaceuticals Corporation of Novartis Finance Corporation, Novartis Corporation, Novartis Holding AG, Novartis AG as corporate parent and/or publicly held company. (Freestone, Amy) [Transferred from mnd on 9/17/2008.] |
| Filing 10 NOTICE of Appearance by Amy R Freestone on behalf of Novartis Pharmaceuticals Corporation (Freestone, Amy) [Transferred from mnd on 9/17/2008.] |
|
Filing 9
ORDER APPROVING re #7 Stipulation regarding Answer pending MDL Transfer filed by Novo Nordisk, Inc. Signed by Magistrate Judge Jeanne J. Graham on 7/28/08. (RLR) [Transferred from mnd on 9/17/2008.]
|
| Filing 8 INITIAL ANSWER to Complaint by Bristol-Myers Squibb Company. (Attachments: #1 Certificate of Service) (Morris, Frederick) [Transferred from mnd on 9/17/2008.] |
| Filing 7 STIPULATION Regarding Extension of Time by Novo Nordisk, Inc.. (Attachments: #1 Certificate of Service)(Newkirk, Christopher) [Transferred from mnd on 9/17/2008.] |
| Filing 6 CERTIFICATE OF SERVICE by Pharmacia and Upjohn Company, Pharmacia Corporation, Pfizer, Inc., Greenstone, Ltd. re #5 Rule 7.1 - Disclosure Statement, #4 Answer to Complaint (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 5 RULE 7.1 DISCLOSURE STATEMENT by Pharmacia and Upjohn Company, Pharmacia Corporation, Pfizer, Inc., Greenstone, Ltd. that there is no such parent or publicly held corporation to report. (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 4 Initial ANSWER to Complaint by Pharmacia and Upjohn Company, Pharmacia Corporation, Pfizer, Inc., Greenstone, Ltd.. (Iversen, Tara) [Transferred from mnd on 9/17/2008.] |
| Filing 3 RULE 7.1 DISCLOSURE STATEMENT by Warner Chilcott, Inc. of Warner Chilcott Corporation and Warner Chilcott Limited as corporate parent and/or publicly held company. (Attachments: #1 Certificate of Service)(Weldon, Melissa) [Transferred from mnd on 9/17/2008.] |
| Filing 2 ANSWER to Complaint by Warner Chilcott, Inc.. (Weldon, Melissa) [Transferred from mnd on 9/17/2008.] |
| Filing 1 COMPLAINT against all defendants ( Filing fee $ 350 receipt number 40025210.) assigned to Judge Ann D Montgomery per Master List and referred to Magistrate Judge Jeanne J Graham, filed by Joann Purdy, Alan Purdy. (Attachments: #1 Civil Cover Sheet) (kt) [Transferred from mnd on 9/17/2008.] |
| Summons Issued as to Wyeth-Ayerst International, Inc., Pharmacia and Upjohn Company, Pharmacia Corporation, Pfizer, Inc., Greenstone, Ltd., Barr Pharmaceuticals, Inc., Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Solvay Pharmaceuticals, Inc., Novo Nordisk, Inc., Novartis Pharmaceuticals Corporation, Mead-Johnson & Company, Warner Chilcott, Inc., Watson Pharmaceuticals, Inc., Wyeth, Inc., Wyeth Pharmaceuticals Inc., ESI Lederle. (kt) [Transferred from mnd on 9/17/2008.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Arkansas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
